GIANLIFE
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
This data is currently unavailable for this company.
Events:
Bonus
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Gian Life Care do?
Gian Life Care Limited offers a wide range of diagnostic tests and healthcare services to individual patients, hospitals, corporates, and healthcare providers including biochemistry, microbiology, radiology, and more.
Who are the competitors of Gian Life Care?
Gian Life Care major competitors are Broach Lifecare Hosp, DhanvantriJeevan Rek, Dr Lalchandani Labs, Clinitech Laboratory, Looks Health Service, Dolphin Medical Serv, Family Care Hospital. Market Cap of Gian Life Care is ₹13 Crs. While the median market cap of its peers are ₹10 Crs.
Is Gian Life Care financially stable compared to its competitors?
Gian Life Care seems to be less financially stable compared to its competitors. Altman Z score of Gian Life Care is 1.98 and is ranked 6 out of its 8 competitors.
Does Gian Life Care pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Gian Life Care latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Gian Life Care allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Gian Life Care balance sheet?
Balance sheet of Gian Life Care is moderately strong.
Is the profitablity of Gian Life Care improving?
The profit is oscillating. The profit of Gian Life Care is ₹4.15 Crs for Mar 2024, ₹1.06 Crs for Mar 2023 and ₹4.37 Crs for Mar 2022
Is the debt of Gian Life Care increasing or decreasing?
Yes, The net debt of Gian Life Care is increasing. Latest net debt of Gian Life Care is -₹1.12 Crs as of Mar-25. This is greater than Mar-24 when it was -₹1.12 Crs.
Is Gian Life Care stock expensive?
Gian Life Care is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE. Latest PE of Gian Life Care is 0.0, while 3 year average PE is 10.71. Also latest EV/EBITDA of Gian Life Care is 14.34 while 3yr average is 5.64.
Has the share price of Gian Life Care grown faster than its competition?
Gian Life Care has given lower returns compared to its competitors. Gian Life Care has grown at ~-33.85% over the last 1yrs while peers have grown at a median rate of -11.84%
Is the promoter bullish about Gian Life Care?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Gian Life Care is 32.09% and last quarter promoter holding is 32.09%.
Are mutual funds buying/selling Gian Life Care?
There is Insufficient data to gauge this.
